C261H430F4N48O66S29 — CID 161087771
N-(2,1,3-benzothiadiazol-4-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(1,3-benzothiazol-5-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(1-benzothiophen-5-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(1,3-benzoxazol-5-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(9H-fluoren-1-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;dodecakis(N-methylpropane-2-sulfonamide);N-[2-methyl-4-(trifluoromethyl)phenyl]-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(4-phenylphenyl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;4-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylcyclohexane-1-carboxamide;4-(propan-2-ylsulfonylamino)-N-[2-(4-sulfamoylphenyl)ethyl]cyclohexane-1-carboxamide;4-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)cyclohexane-1-carboxamide;4-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)cyclohexane-1-carboxamide (PubChem CID 161087771) has the molecular formula C261H430F4N48O66S29 and a molecular weight of 6302.52 g/mol. Its IUPAC name is N-(2,1,3-benzothiadiazol-4-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(1,3-benzothiazol-5-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(1-benzothiophen-5-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(1,3-benzoxazol-5-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(9H-fluoren-1-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;dodecakis(N-methylpropane-2-sulfonamide);N-[2-methyl-4-(trifluoromethyl)phenyl]-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(4-phenylphenyl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;4-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylcyclohexane-1-carboxamide;4-(propan-2-ylsulfonylamino)-N-[2-(4-sulfamoylphenyl)ethyl]cyclohexane-1-carboxamide;4-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)cyclohexane-1-carboxamide;4-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)cyclohexane-1-carboxamide.
| Compound Name | N-(2,1,3-benzothiadiazol-4-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(1,3-benzothiazol-5-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(1-benzothiophen-5-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(1,3-benzoxazol-5-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(9H-fluoren-1-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;dodecakis(N-methylpropane-2-sulfonamide);N-[2-methyl-4-(trifluoromethyl)phenyl]-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(4-phenylphenyl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;4-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylcyclohexane-1-carboxamide;4-(propan-2-ylsulfonylamino)-N-[2-(4-sulfamoylphenyl)ethyl]cyclohexane-1-carboxamide;4-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)cyclohexane-1-carboxamide;4-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)cyclohexane-1-carboxamide |
|---|---|
| PubChem CID | 161087771 |
| Molecular Formula | C261H430F4N48O66S29 |
| Molecular Weight | 6302.52 g/mol |
| Exact Mass | 6296.36 |
| IUPAC Name | N-(2,1,3-benzothiadiazol-4-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(1,3-benzothiazol-5-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(1-benzothiophen-5-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(1,3-benzoxazol-5-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(9H-fluoren-1-yl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;dodecakis(N-methylpropane-2-sulfonamide);N-[2-methyl-4-(trifluoromethyl)phenyl]-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;N-(4-phenylphenyl)-4-(propan-2-ylsulfonylamino)cyclohexane-1-carboxamide;4-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylcyclohexane-1-carboxamide;4-(propan-2-ylsulfonylamino)-N-[2-(4-sulfamoylphenyl)ethyl]cyclohexane-1-carboxamide;4-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)cyclohexane-1-carboxamide;4-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)cyclohexane-1-carboxamide |
| SMILES | CC(C)S(=O)(=O)NC1CCC(C(=O)NCCc2ccc(S(N)(=O)=O)cc2)CC1.CC(C)S(=O)(=O)NC1CCC(C(=O)Nc2ccc(-c3ccccc3)cc2)CC1.CC(C)S(=O)(=O)NC1CCC(C(=O)Nc2ccc3ocnc3c2)CC1.CC(C)S(=O)(=O)NC1CCC(C(=O)Nc2ccc3sccc3c2)CC1.CC(C)S(=O)(=O)NC1CCC(C(=O)Nc2ccc3scnc3c2)CC1.CC(C)S(=O)(=O)NC1CCC(C(=O)Nc2cccc3c2Cc2ccccc2-3)CC1.CC(C)S(=O)(=O)NC1CCC(C(=O)Nc2cccc3nsnc23)CC1.CC(C)S(=O)(=O)NC1CCC(C(=O)Nc2ncccn2)CC1.CC(C)S(=O)(=O)NC1CCC(C(=O)Nc2ncncn2)CC1.CC(C)S(=O)(=O)NC1CCC(C(=O)Nc2nnc(-c3ccc(F)cc3)s2)CC1.CNS(=O)(=O)C(C)C.CNS(=O)(=O)C(C)C.CNS(=O)(=O)C(C)C.CNS(=O)(=O)C(C)C.CNS(=O)(=O)C(C)C.CNS(=O)(=O)C(C)C.CNS(=O)(=O)C(C)C.CNS(=O)(=O)C(C)C.CNS(=O)(=O)C(C)C.CNS(=O)(=O)C(C)C.CNS(=O)(=O)C(C)C.CNS(=O)(=O)C(C)C.COc1cc(NC(=O)C2CCC(NS(=O)(=O)C(C)C)CC2)cc(OC)c1OC.Cc1cc(C(F)(F)F)ccc1NC(=O)C1CCC(NS(=O)(=O)C(C)C)CC1 |
| InChI | InChI=1S/C23H28N2O3S.C22H28N2O3S.C19H30N2O6S.C18H25F3N2O3S.C18H23FN4O3S2.C18H29N3O5S2.C18H24N2O3S2.C17H23N3O4S.C17H23N3O3S2.C16H22N4O3S2.C14H22N4O3S.C13H21N5O3S.12C4H11NO2S/c1-15(2)29(27,28)25-18-12-10-16(11-13-18)23(26)24-22-9-5-8-20-19-7-4-3-6-17(19)14-21(20)22;1-16(2)28(26,27)24-21-14-10-19(11-15-21)22(25)23-20-12-8-18(9-13-20)17-6-4-3-5-7-17;1-12(2)28(23,24)21-14-8-6-13(7-9-14)19(22)20-15-10-16(25-3)18(27-5)17(11-15)26-4;1-11(2)27(25,26)23-15-7-4-13(5-8-15)17(24)22-16-9-6-14(10-12(16)3)18(19,20)21;1-11(2)28(25,26)23-15-9-5-12(6-10-15)16(24)20-18-22-21-17(27-18)13-3-7-14(19)8-4-13;1-13(2)28(25,26)21-16-7-5-15(6-8-16)18(22)20-12-11-14-3-9-17(10-4-14)27(19,23)24;1-12(2)25(22,23)20-15-5-3-13(4-6-15)18(21)19-16-7-8-17-14(11-16)9-10-24-17;2*1-11(2)25(22,23)20-13-5-3-12(4-6-13)17(21)19-14-7-8-16-15(9-14)18-10-24-16;1-10(2)25(22,23)20-12-8-6-11(7-9-12)16(21)17-13-4-3-5-14-15(13)19-24-18-14;1-10(2)22(20,21)18-12-6-4-11(5-7-12)13(19)17-14-15-8-3-9-16-14;1-9(2)22(20,21)18-11-5-3-10(4-6-11)12(19)17-13-15-7-14-8-16-13;12*1-4(2)8(6,7)5-3/h3-9,15-16,18,25H,10-14H2,1-2H3,(H,24,26);3-9,12-13,16,19,21,24H,10-11,14-15H2,1-2H3,(H,23,25);10-14,21H,6-9H2,1-5H3,(H,20,22);6,9-11,13,15,23H,4-5,7-8H2,1-3H3,(H,22,24);3-4,7-8,11-12,15,23H,5-6,9-10H2,1-2H3,(H,20,22,24);3-4,9-10,13,15-16,21H,5-8,11-12H2,1-2H3,(H,20,22)(H2,19,23,24);7-13,15,20H,3-6H2,1-2H3,(H,19,21);2*7-13,20H,3-6H2,1-2H3,(H,19,21);3-5,10-12,20H,6-9H2,1-2H3,(H,17,21);3,8-12,18H,4-7H2,1-2H3,(H,15,16,17,19);7-11,18H,3-6H2,1-2H3,(H,14,15,16,17,19);12*4-5H,1-3H3 |
| InChIKey | UGTHGLSQBLTRTO-UHFFFAOYSA-N |
| XLogP | 32.03 |
| TPSA | 1700.06 Ų |
| H-Bond Donors | 37 |
| H-Bond Acceptors | 81 |
| Rotatable Bonds | 92 |
| Heavy Atoms | 408 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 6302.52 |
| LogP ≤ 5 | 32.03 |
| H-Bond Donors ≤ 5 | 37 |
| H-Bond Acceptors ≤ 10 | 81 |